Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
about
Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisMicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerRoles of miR-182 in sensory organ development and cancermiRNAs associated with prostate cancer risk and progressionMicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.MicroRNAs as potential biomarkers in cancer: opportunities and challengesMiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.Prognostic Value of MicroRNA-182 in Cancers: A Meta-AnalysisUsing gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discoveryLow miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.Identification of microRNA signature and potential pathway targets in prostate cancer.miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.The roles of microRNAs in the progression of castration-resistant prostate cancer.Genome wide predictions of miRNA regulation by transcription factors.MicroRNA-187 induces diffuse large B-cell lymphoma cell apoptosis via targeting BCL6.Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma.Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation.A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1.Mangiferin inhibition of proliferation and induction of apoptosis in human prostate cancer cells is correlated with downregulation of B-cell lymphoma-2 and upregulation of microRNA-182.Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort StudyMiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin.MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1.Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?Current Research on Non-Coding Ribonucleic Acid (RNA).Stromal factors involved in human prostate cancer development, progression and castration resistance.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.Molecular and cellular mechanisms of castration resistant prostate cancer.In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.
P2860
Q26747871-6CFDC070-9E5A-4666-83FE-D1E363C89C39Q26751983-86F94C0E-52BE-4A0A-9921-6A2FD460D0B2Q26798264-1E92762C-9287-45FA-8FFC-EBC0513C93C5Q30235186-6EC32849-ECC4-46BD-859C-5C2AE86A7B6FQ34448246-0CED96F5-86B2-444B-87C0-88BC8060BC48Q35271157-DA39BFC1-58D1-4B44-B893-725B1E62EDEDQ35602182-D9FE5DE2-7A8B-4EFE-8A0C-97CDF3DDC8CAQ35630616-4A4E938C-078A-483E-BDF5-75D12A37DAF7Q35917562-5612C000-D086-4B8A-9916-59830F2E35C8Q37113174-C0E19A57-042E-45D9-8FFF-9327BE251D21Q37353927-7817EDCD-D808-4B04-A084-3A867CA97E4FQ37582591-90B43CAA-40FC-452B-90F4-E0F3CFB0D487Q37641610-C381698D-5075-4875-9508-0D0CF70F6C3AQ38728193-30024288-DEDC-43B2-BF24-D052809D713EQ38737112-B2F4F849-49CC-4357-A6A7-BE29BB51504CQ38782961-5A01DAFE-7214-4466-A4F5-624A20ACC7C8Q38835737-4C274C8B-105B-47FF-8A81-89EE8F06A96CQ38859577-BFF80CB0-B461-4932-B1EB-4351C0BC4F67Q39429293-C2A13029-09FA-4CB0-AD66-C33C97A54855Q39647418-B304A97B-FF03-4FDA-BB11-3F9DF774431AQ40394844-908EAA3A-A04A-4729-88A0-559ED543E81AQ40746143-96F5593F-CA71-4491-A31F-5A8A3041D94BQ41242139-DACC66C3-DDF2-40D7-A518-AB2E9BBCF2B0Q41867031-4769F1AB-90CD-4A38-96F5-625DF226403AQ41871428-6D07D208-0A55-47D0-9EBB-F0562209B221Q42040192-72F15C0C-87A2-4AEF-AC30-2318775F6803Q43174416-72EE4FFC-5B70-4D42-A6A4-2318D3974C27Q43178497-ADDB4D63-50F3-4C8D-874B-B443BAD198FDQ45324940-9F66B9D2-630E-47CA-98D6-BAF944AFD87CQ47109138-F0725E91-F918-4003-8C2C-66772B71C02DQ47669687-D2ED0E3F-3559-4B4E-B1C9-B395868CF1FFQ48145024-64A56C30-5A89-490A-A230-96E1C1F9D63AQ48225109-BC16013F-D39B-42B0-8613-1857CBC297BFQ49749406-B3847A96-0B41-41B9-A5B9-973B3CDE0FF9Q51360042-F6794BF5-D624-4838-ADF6-966F5934639BQ52589516-E9BDF063-A90F-443B-8468-D5FAB4AA2377Q52608488-BB0E7301-6499-4BE5-8444-DF3B46A8B617Q55095957-149A2A5F-DE2E-4555-BF0F-301FF37087EF
P2860
Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Identification of miR-187 and ...... ed with radical prostatectomy.
@en
Identification of miR-187 and ...... ed with radical prostatectomy.
@nl
type
label
Identification of miR-187 and ...... ed with radical prostatectomy.
@en
Identification of miR-187 and ...... ed with radical prostatectomy.
@nl
prefLabel
Identification of miR-187 and ...... ed with radical prostatectomy.
@en
Identification of miR-187 and ...... ed with radical prostatectomy.
@nl
P2093
P50
P1476
Identification of miR-187 and ...... ted with radical prostatectomy
@en
P2093
Ana Calatrava
Antonio Fernández-Serra
Esther Masiá
Francisco Martínez
José Antonio López-Guerrero
José Domínguez-Escrig
José Rubio-Briones
Juan Casanova
Luis Rubio
Zaida García-Casado
P304
P356
10.1016/J.JURO.2014.01.107
P407
P50
P577
2014-02-08T00:00:00Z